- HCC-78
- HDLM-2
- DOHH-2
- L-540
- MX-1
- NALM-6
- NB-4
- CAL-51
- SNB-19
- KYSE-520
- MKN-45
- BA/F3
- MS-5
- HCEC-B4G12
- NK-92
- PA-TU-8988S
- MONO-MAC-1
- PA-TU-8902
- Human Microglia
- Human Hepatic Stellate Cells
- Human Skeletal Muscle Cells (DMD)
- Human Schwann Cells
- Human Oral Keratinocytes (HOK)
- Human Cardiomyocytes
- Human Small Intestinal Epithelial Cells
- Human Colonic Epithelial Cells
- Human Intestinal Fibroblasts
- Primary Human Large Intestine Microvascular Endothelial Cells
- Human Small Intestinal Microvascular Endothelial Cells
- Human Retinal Pigment Epithelial Cells
- Human Hepatocytes
- Cynomolgus Monkey Lung Microvascular Endothelial Cells
- Cynomolgus Monkey Vein Endothelial Cells
- C57BL/6 Mouse Primary Mammary Epithelial Cells
- C57BL/6 Mouse Vein Endothelial Cells
- Rat Primary Kidney Epithelial Cells
- Rat Gingival Epithelial Cells
- Rabbit Lung Endothelial Cells
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
Acute Lymphoid Leukemia Bone Marrow Plasma (Relapsed/Refractory)
Cat.No.:CSC-C4599X
Species: Human
Source: Bone Marrow
- Specification
- Background
- Scientific Data
- Q & A
- Customer Review
- Documents
- Publications
This is the FDA licensed product name for plasma collected via plasmapheresis. By definition, it must be frozen at -20℃ or colder and placed at that temperature within 30 minutes. Average size is ~ 880 mls. Most common anticoagulant is 4% Sodium Citrate.
Plasma makes up 55% of your blood’s total volume. Red blood cells follow at 44% of your blood’s volume, and a combination of white blood cells and platelets fill the remaining 1%.
Average Rating: 5.0 | 1 Scientist has reviewed this product
Satisfying
We have cooperated for many years, and hope you get better and better.
14 Jan 2023
Ease of use
After sales services
Value for money
Description: Human bone marrow stromal cells or mesenchymal stem cells (MSCs) are derived from bone marrow mononuclear cells. MSCs are isolated from a single donor. MSCs are one of the most investigated cells for therapeutic applications. These cells enable researchers to investigate stem cell properties, regenerative medicine, and tissue engineering. In addition, they may be used for developmental studies.
Development period: Postnatal
Description: Human bone marrow plasma is the liquid component of blood. Bone marrow plasma consists of dissolved proteins, glucose, clotting agents, minerals, hormones, and carbon dioxide. It makes up approximately 55% of the whole bone marrow suspension. This whole bone marrow plasma is isolated from a single donor. The plasma is separated out from the whole bone marrow (sent separately) and immediately frozen at -80°C in order to preserve its contents. Whole bone marrow plasma enables researchers to investigate specific components of bone marrow at the molecular level.
Development period: Postnatal
Description: Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are density separated by Ficoll-Paque to enrich mononuclear cells from the bone marrow. Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are available in untreated and relapsed/refractory stages.
Description: Bone Marrow is obtained from adult Myelodysplastic Syndrome patients. Bone Marrow-Mononuclear Cells are isolated by diluting the bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation,the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate cell subpopulations. Myelodysplastic Syndrome-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages.
Description: Bone Marrow is obtained from adult Myelodysplastic Syndrome patients. Bone Marrow-Mononuclear Cells are isolated by diluting the bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation,the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate cell subpopulations. Myelodysplastic Syndrome-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages.
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages.
